British American Tobacco working on Covid-19 vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Monday
July 04, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
MONDAY, JULY 04, 2022
British American Tobacco working on Covid-19 vaccine

Coronavirus chronicle

TBS Report
02 April, 2020, 12:50 pm
Last modified: 02 April, 2020, 05:52 pm

Related News

  • China slashes Covid quarantine time for international travellers
  • BAT wins maiden StanChart ‘Symphony – Brands in Sync’ musical contest 
  • Vaccination for Cholera begins in Dhaka on Sunday
  • Bavarian Nordic eyes more monkeypox vaccine orders amid global 'wake-up call'
  • WTO seeks fish, vaccine deals as war ignites trade tensions

British American Tobacco working on Covid-19 vaccine

If the testing goes well, one to three million doses of the vaccine could be manufactured per week

TBS Report
02 April, 2020, 12:50 pm
Last modified: 02 April, 2020, 05:52 pm
British American Tobacco working on Covid-19 vaccine

British American Tobacco is in the pre-clinical testing of developing a potential vaccine for Covid-19.

If the testing, which is being done by BAT's US biotech subsidiary Kentucky Bio Processing (KBP), goes well, BAT hopes to manufacture between one and three million doses of the vaccine per week, beginning in June, with the right partners and support from government agencies, said a press release.
 
While KBP remains a commercial operation, its work around the Covid-19 vaccine project will be carried out on a not-for-profit basis.

The vaccine being developed uses BAT's proprietary, fast-growing tobacco plant technology which has several advantages over conventional vaccine production technology.

It is potentially safer given that tobacco plants cannot host pathogens which cause human diseases. It is faster because the elements of the vaccine accumulate in tobacco plants much more quickly – in 6 weeks – whereas it takes several months using conventional methods. 
 
The vaccine formulation KBP is developing remains stable at room temperature, unlike conventional vaccines which often require refrigeration. And, it has the potential to deliver an effective immune response in a single dose.

KBP recently cloned a portion of Covid-19's genetic sequence which led to the development of a potential antigen – a substance which induces an immune response in the body and in particular, the production of antibodies. This antigen was then inserted into tobacco plants for reproduction and, once the plants were harvested, the antigen was then purified, and is now undergoing pre-clinical testing.

BAT is now exploring partnerships with government agencies to bring its vaccine to clinical studies as soon as possible. Through collaboration with government and third-party manufacturers, BAT believes that between 1 and 3 million doses per week could be manufactured.
 
Dr David O'Reilly, director of scientific research at BAT, said, "Vaccine development is challenging and complex work, but we believe we have made a significant break-through with our tobacco plant technology platform, and stand ready to work with Governments and all stakeholders to help win the war against Covid-19. 

We fully align with the United Nations plea for a whole-of-society approach to combat global problems. And, we are committed to contributing to the global effort to halt the spread of Covid-19 using this technology."
 
BAT's US subsidiary, Reynolds American Inc, acquired KBP in 2014, intending to use some of its unique tobacco extraction technology to aid further development of its new category – non-combustible products.

In 2014, KBP made headlines as one of the few companies with an effective treatment for Ebola, having manufactured ZMapp™ with California-based company Mapp BioPharmaceuticals in partnership with the US Biomedical Advanced Research and Development Authority.

Top News

Coronavirus / British American Tobacco / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Nomura says many major economies will hit recession by 2023
  • Japanese Ambassador Naoki Ito. Sketch: TBS
    'The game-changing projects are in line with the Bay of Bengal Industrial Growth Belt initiative'
  • Photo: Collected
    Train leaves behind over 100 passengers as bogie malfunctions

MOST VIEWED

  • A man helps his son to wear mask at Covid-19 test centre at KSRTC bus stand in Bengaluru.(PTI)
    India records 16,103 new Covid cases, 31 deaths in 24 hours
  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters

Related News

  • China slashes Covid quarantine time for international travellers
  • BAT wins maiden StanChart ‘Symphony – Brands in Sync’ musical contest 
  • Vaccination for Cholera begins in Dhaka on Sunday
  • Bavarian Nordic eyes more monkeypox vaccine orders amid global 'wake-up call'
  • WTO seeks fish, vaccine deals as war ignites trade tensions

Features

Last month Swapan Kumar Biswas, the acting principal of Mirzapur United College, was forced to wear a garland of shoes for ‘hurting religious sentiments.’ Photo: Collected

Where do teachers rank in our society?

4h | Panorama
Japanese Ambassador Naoki Ito. Sketch: TBS

'The game-changing projects are in line with the Bay of Bengal Industrial Growth Belt initiative'

6h | Panorama
A Glittery Eid

A Glittery Eid

1d | Mode
Rise’s target customers are people who crave to express themselves through what they wear, and their clothing line is not relegated to any age range.

Level up your Eid game with Rise

1d | Mode

More Videos from TBS

Photo: TBS

Jahangirnagar University protest recent harassment of teachers

1h | Videos
Sanitary Napkin vending machines makes life easier for CU students

Sanitary Napkin vending machines makes life easier for CU students

4h | Videos
Photo: TBS

Covid deaths, cases again on the rise

4h | Videos
Is the Western intention to defeat Russia through Ukraine successful?

Is the Western intention to defeat Russia through Ukraine successful?

17h | Videos

Most Read

1
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

2
TBS Illustration
Education

Universities may launch online classes again after Eid

3
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

4
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

5
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

6
Investor Hiru fined Tk2cr for market manipulation
Stocks

Investor Hiru fined Tk2cr for market manipulation

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Sun Drying Paddy in Monsoon: Workers in a rice mill at Shonarumpur in Ashuganj arrange paddy grains in lumps on an open field to dry out moisture through sunlight. During the rainy season, workers have to take cautions so that the grains do not get wet in the rains. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net